These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25720713)

  • 1. Combination of thrombolytic therapy and neuroprotective therapy in acute ischemic stroke: is it important?
    Wang Y; Li Q; Wang J; Zhuang QK; Zhang YY
    Eur Rev Med Pharmacol Sci; 2015; 19(3):416-22. PubMed ID: 25720713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator.
    Roncal C; Martinez de Lizarrondo S; Salicio A; Chevilley A; Rodriguez JA; Rosell A; Couraud PO; Weksler B; Montaner J; Vivien D; Páramo JA; Orbe J
    Cardiovasc Res; 2017 Aug; 113(10):1219-1229. PubMed ID: 28379489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
    Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I
    Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
    Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
    FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
    Liu S; Feng X; Jin R; Li G
    Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute ischemic stroke: comparison of low-dose and standard-dose regimes of tissue plasminogen activator.
    Sharma VK; Kawnayn G; Sarkar N
    Expert Rev Neurother; 2013 Aug; 13(8):895-902. PubMed ID: 23965163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraarterial thrombolysis within the first three hours after acute ischemic stroke in selected patients.
    Moonis M
    Stroke; 2009 Jul; 40(7):2611-2. PubMed ID: 19443796
    [No Abstract]   [Full Text] [Related]  

  • 9. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.
    Paul CL; Ryan A; Rose S; Attia JR; Kerr E; Koller C; Levi CR
    Implement Sci; 2016 Apr; 11():51. PubMed ID: 27059183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The future perspective of acute thrombolytic therapy for acute ischemic stroke].
    Matsuki T; Toyoda K
    Nihon Rinsho; 2016 Apr; 74(4):613-20. PubMed ID: 27333749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model.
    Culp WC; Brown AT; Lowery JD; Arthur MC; Roberson PK; Skinner RD
    Mol Neurobiol; 2015 Oct; 52(2):979-84. PubMed ID: 26055229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
    Jahan R; Vinuela F
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on "Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008".
    Sharma VK; Teoh HL; Chan BP
    J Clin Neurosci; 2010 Apr; 17(4):543-4. PubMed ID: 20167497
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in older adults.
    Dirks M; Koudstaal PJ; Dippel DW; Niessen LW; van Wijngaarden JD; Franke CL; van Oostenbrugge RJ
    J Am Geriatr Soc; 2011 Nov; 59(11):2169-71. PubMed ID: 22098036
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperacute therapy of acute ischemic stroke: intraarterial thrombolysis and mechanical revascularization strategies.
    Jahan R
    Tech Vasc Interv Radiol; 2005 Jun; 8(2):87-91. PubMed ID: 16194756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.
    Tsivgoulis G; Kargiotis O; Alexandrov AV
    Expert Rev Neurother; 2017 Aug; 17(8):819-837. PubMed ID: 28644924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of adjunctive treatments for acute stroke thrombolysis: a review of clinical evidence.
    Zhou H; Huang S; Sunnassee G; Guo W; Chen J; Guo Y; Tan S
    Int J Neurosci; 2017 Nov; 127(11):1036-1046. PubMed ID: 28110588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Matters in the Results of Repeated Intravenous Thrombolysis for Recurrent Ischemic Stroke?
    Wu J; Huang Q; Ma QF
    Eur Neurol; 2016; 75(3-4):150-4. PubMed ID: 26950942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.